Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Open accessThe DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index; 127 of the 159 sources its claims cite were checked for support.
Abstract
Review of antifungal heteroresistance as a reversible minority subpopulation phenomenon distinct from tolerance and persistence, with clinical implications for survival and treatment failure.
Overview
CoChat Summary
TL;DR
Antifungal heteroresistance is a reversible, often inducible phenotype in which a minority resistant fungal subpopulation coexists with a susceptible majority, complicating susceptibility testing and treatment. This narrative review summarizes known mechanisms—especially aneuploidy/copy number variation and gene-expression changes—and clinical implications, while noting that fungal heteroresistance remains underexplored compared with bacterial heteroresistance.
Key findings
- Heteroresistance can involve resistant subpopulations as rare as one in one million cells and may cause treatment failure, breakthrough infection, relapse, or prophylaxis failure despite in vitro susceptibility.
- Aneuploidy and copy number variations are central mechanisms, with examples including chr5/ERG11/TAC1 in *C. albicans*, chrE in *N. glabrata*, chr1 disomy in *C. neoformans*, and cross-resistance to azoles and 5-FC after fluconazole exposure.
- Clinical impact is substantial: invasive fungal infection mortality ranges from 40% to 70% in candidiasis, 40% to 80% in cryptococcosis, and can exceed 90% in aspergillosis; untreated high-level heteroresistant brain-infected mice reached 100% 20-day mortality.
- Conventional MIC-based testing may miss heteroresistant subpopulations; population analysis profile (PAP) is recommended as the gold standard, with time-kill and single-cell assays as additional approaches. No approved first-line therapies exist, though combination therapy or dose escalation may help, and adding 5-FC or amphotericin B to fluconazole monotherapy has achieved up to 90% efficacy in some settings.
Methods
- Narrative review of antifungal heteroresistance, tolerance, and persistence, synthesizing mechanisms and clinical relevance.
- Literature identified through PubMed and Web of Science using keywords “antifungal heteroresistance,” “antifungal resistance,” “antifungal tolerance,” and “antifungal persistence”; articles from 1995 to 2025 were considered.
- Priority given to peer-reviewed research articles, reviews, and case reports relevant to clinical microbiology and antifungal therapy; non-English articles, conference abstracts, and studies with ambiguous definitions or lacking direct relevance were excluded.
Limitations
- Stated: fungal heteroresistance remains largely underexplored, most research focuses on azole resistance, clinically important mechanisms have not been studied in sufficient depth, and comparative studies and clinical trials remain limited.
- Stated: mechanisms of stress induction and the genes involved in some heteroresistance phenotypes need further exploration.
- Evident from the text: as a narrative review, it does not provide a systematic quantitative synthesis or meta-analysis, and it notes ongoing definitional overlap between heteroresistance, tolerance, and persistence in the literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Antifungal mode of action of azoles, AMB, 5-FC and echinocandins. Azoles inhibit ergosterol biosynthesis by targeting sterol 14α-demethylase, producing toxic 14-methyl sterols, altering fungal cell membrane permeability and metabolic state [74,75]. Echinocandins target β-1,3-glucan synthase, impairing fungal cell wall integrity and stress resistance [76]. Amphotericin B binds to membrane ergosterol, forming pores that disrupt permeability and cause reactive oxygen species (ROS) accumulation, leading to cell death [77,78,79]. 5-FC is converted intracellularly to 5-FU, inhibiting DNA and RNA synthesis [80,81].](https://figures.cochat.ai/paper-figures/ff01be48efb7424f88ea0cf1437ad8b2/insight-into-the-mechanisms-and-clinical-relevance-of-antifungal-figure-1.jpg)

Verification
Claims the paper makes
90 Valid · 4 Not valid · 14 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Bosch et al. demonstrated that environmental stress, such as the nitrogen limitation commonly encountered in its natural habitats, increases the resistance of C. neoformans to AmB and fluconazole, and increases the frequency of heterogeneous resistance to fluconazole [57].”
§ Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance > 7. Mechanisms of Antifungal Heteroresistance > 7.3. Environmental Stress Induction
What the sources say
- Disputedcites [57] Bosch, 2020, Nitrogen concentration affects amphotericin B and fluconazole tolerance of pathogenic cryptococci, FEMS Yeast Res. sourceExperimental — accuracy not yet measured
The ‘Frequency of fluconazole heteroresistance/tolerance’ section reports a higher combined frequency under low nitrogen, but identifies only C. gattii CAB 761 as heteroresistant. It classifies the tested C. neoformans strains as fluconazole-tolerant, not heteroresistant. No page number is available in our copy. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“For example it was found that C. neoformans heteroresistance was detected at 35 °C but not at 30 °C, indicating the importance of environmental temperature [19].”
§ Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance > 7. Mechanisms of Antifungal Heteroresistance > 7.3. Environmental Stress Induction
What the sources say
- Disputedcites [19] Yamazumi, 2003, Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans, J. Clin. Microbiol. sourceExperimental — accuracy not yet measured
The Results state the opposite of the cited claim: heteroresistance was absent at 35°C and demonstrable only at 30°C in agar-based tests. The paper's opening summary reports the same temperature dependence. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“For example it was found that C. neoformans heteroresistance was detected at 35 °C but not at 30 °C, indicating the importance of environmental temperature [19].”
§ Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance > 7. Mechanisms of Antifungal Heteroresistance > 7.3. Environmental Stress Induction
What the sources say
- Disputedcites [19] Yamazumi, 2003, Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans, J. Clin. Microbiol. sourceExperimental — accuracy not yet measured
The Results section reports the opposite temperature pattern: heteroresistance was absent at 35°C and demonstrable only at 30°C in agar-based tests. The Discussion confirms that incubation temperature affected the phenotype, but the citing sentence reverses the study’s finding. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, some 5–90% of the tolerant cells can slowly proliferate [105].”
§ Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance > 4. Heteroresistance, Tolerance and Persistence of Antifungal Drugs
What the sources say
- Partly supportedcites [105] Berman, 2020, Drug resistance and tolerance in fungi, Nat. Rev. Microbiol. sourceExperimental — accuracy not yet measured
The Introduction says that slowly growing tolerant cells make up 5–90% of all cells in an isolate, depending on the isolate. The citing sentence instead makes 5–90% a fraction of the tolerant cells, changing the denominator. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Repeated culture in stress-free environments can abolish heteroresistance [48].”
§ Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance > 4. Heteroresistance, Tolerance and Persistence of Antifungal Drugs
What the sources say
- Partly supportedcites [48] Ferreira, 2015, Heteroresistance to Itraconazole Alters the Morphology and Increases the Virulence of Cryptococcus gattii, Antimicrob. Agents Chemother. sourceExperimental — accuracy not yet measured
The Results report that highly resistant C. gattii subclones returned to their initial itraconazole susceptibility after 10 subcultures in drug-free medium. But the paper also says the original strains exhibited heteroresistance, so the experiment shows loss of the elevated resistance level, not abolition of heteroresistance altogether. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
86 more claims · 62 with their cited sources checked
Create a free account to see all 136 claims and every source verdict.
- It may state two separate claims as one. 41
- Probably not a substantial claim. 10
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In multiple murine infection models, Heteroresistant strains can lead to increased fungal burden and reduced treatment efficacy [28,29].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“This reproducible rebound trajectory provides direct evidence that the HR subpopulation is not merely tolerant but can proliferate under ongoing drug pressure [8]”
From Calcineurin‐Dependent Stress Adaptation Enables Caspofungin Heteroresistance Leading to Stable Resistance in Candida Glabrata (2026) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance > 3. Antifungal Resistance Mechanisms
“Once inside the cell, 5-FC is converted to 5-fluorouracil (5-FU) through the action of cytosine deaminase and uracil phosphoribosyl transferase, both encoded by the FCY1 gene, inhibiting DNA and RNA biosynthesis [80,81].”
§ Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance > 3. Antifungal Resistance Mechanisms
“FCY1 encoding the cytosine deaminase, FUR1 encoding the uracil phosphoribosyl transferase”
Citations
Cites
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 1×
“Persistence is always linked to cell dormancy, a state in which the cellular metabolism temporarily ceases [111,123,124].”
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858 · cited 1×
“Persistence is always linked to cell dormancy, a state in which the cellular metabolism temporarily ceases [111,123,124].”
Global incidence and mortality of severe fungal disease
Denning, D. W. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00692-8 · Cited by 1,640 · cited 2×
“Fungi are signi fi cant eukaryotic pathogens in humans capable of causing infections ranging from super fi cial to life-threatening systemic diseases [8,31–40].”
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
The global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Garcia-Vidal, C., Sanjuan, G., Moreno-García, E., Puerta-Alcalde, P., Garcia-Pouton, N., Chumbita, M., Fernandez-Pittol, M., Pitart, C., Inciarte, A., Bodro, M., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.041 · Cited by 1,022
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733 · cited 3×
“By altering gene dosage or expression levels, aneuploidy allows fungi to quickly adjust to adverse conditions without permanent genetic mutations, promoting survival in fluctuating environments [99,129,145,152,154].”
Resistance of Candida to azoles and echinocandins worldwide
Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642 · cited 1×
“Furthermore, some 5–90% of the tolerant cells can slowly proliferate [105].”
Urease as a Virulence Factor in Experimental Cryptococcosis
Cox, G. M., Mukherjee, J., Cole, G. T., Casadevall, A., & Perfect, J. R. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.443-448.2000 · Cited by 522 · cited 2×
“…adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, 68, 68, 69] 69 , ], etc. etc.”
Mechanisms and clinical relevance of bacterial heteroresistance
Andersson, D. I., Nicoloff, H., & Hjort, K. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0218-1 · Cited by 513 · cited 1×
“Monoclonal heteroresistance is pure clones [18].”
Antimicrobial heteroresistance: An emerging field in need of clarity
El-Halfawy, O. M., & Valvano, M. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-14 · Cited by 489 · cited 1×
“For heteroresistance, the population analysis profile (PAP) assay is recommended as the gold standard [169].”
Sionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479 · cited 1×
“If any of the ERG11 , SEY1 , GCS2 or GLO3 genes are relocated to chr3, then the frequency of chr3 disomy could increase [143,144].”
Azole antifungal agents: Emphasis on new triazoles
Saag, M. S., & Dismukes, W. E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.1 · Cited by 474
Systematic Genetic Analysis of Virulence in the Human Fungal Pathogen Cryptococcus neoformans
Liu, O. W., Chun, C. D., Chow, E. D., Chen, C., Madhani, H. D., & Noble, S. M. (2008) · Cell · doi:10.1016/j.cell.2008.07.046 · Cited by 443
Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · cited 1×
“TAC1 encodes a transcription regulator of ABC transporter genes located on chr3 [156].”
Bet Hedging in Yeast by Heterogeneous, Age-Correlated Expression of a Stress Protectant
Levy, S. F., Ziv, N., & Siegal, M. L. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001325 · Cited by 371 · cited 1×
“From the perspective of population evolution, it can be seen as a strategy that helps the fungal population survive diverse environments [100].”
Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362 · cited 1×
“In addition, activation of cellular stress response pathways, such as the heat shock protein (Hsp) and calcineurin pathways, has been shown to contribute to echinocandin tolerance in C. albicans [120,121].”
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans
Cox, G. M., McDade, H. C., Chen, S. C. A., Tucker, S. C., Gottfredsson, M., Wright, L. C., Sorrell, T. C., Leidich, S. D., Casadevall, A., Ghannoum, M. A., et al. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02236.x · Cited by 362
Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323 · cited 1×
“Currently, resistance to echinocandins is mainly associated with mutations in the FKS1/FKS2 genes [82,90,91].”
Polysaccharide antigens of the capsule of Cryptococcus neoformans
Cherniak, R., & Sundstrom, J. B. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.1507-1512.1994 · Cited by 320 · cited 2×
“Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67],…”
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Mesa-Arango, A. C., Scorzoni, L., & Zaragoza, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00286 · Cited by 311 · cited 1×
“Resistance to AmB in both species involves a variety of mechanisms, including alterations in cell membrane composition, cellular metabolic state, iron homeostasis, and ROS metabolism [58,77,78,96].”
Olszewski, M. A., Noverr, M. C., Chen, G.-H., Toews, G. B., Cox, G. M., Perfect, J. R., & Huffnagle, G. B. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63734-0 · Cited by 289 · cited 2×
“…stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue…”
Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Candida albicans biofilms and polymicrobial interactions
Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843400 · Cited by 281
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270 · cited 2×
“The reversibility of this property has been con fi rmed for several fungi species [107,108].”
Mode of action of 5-fluorocytosine and mechanisms of resistance
Polak, A., & Scholer, H. J. (2009) · Chemotherapy · doi:10.1159/000221854 · Cited by 250
Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018
Rayens, E., & Norris, K. A. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab593 · Cited by 228
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222 · cited 1×
“Persistence is always linked to cell dormancy, a state in which the cellular metabolism temporarily ceases [111,123,124].”
Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 205 · cited 1×
“…to echinocandins, but considering their small effect on caspofungin resistance or the concurrent occurrence with FKS2 mutations, it is more likely that they create a genetic background in which the FKS2 mutations are adaptive and less harmful, rather than a direct cause of resistance [92].”
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts
D’Souza, C. A., Kronstad, J. W., Taylor, G., Warren, R., Yuen, M., Hu, G., Jung, W. H., Sham, A., Kidd, S. E., Tangen, K., et al. (2011) · mBio · doi:10.1128/mbio.00342-10 · Cited by 202 · cited 1×
“The main mechanisms that could be related to C. gattii heteroresistance are copy number increase in chr10, chr9 and chr11 for the VGI genotype and copy number increase in chr3 for the VGII genotype [138].”
Persisters and beyond: Mechanisms of phenotypic drug resistance and drug tolerance in bacteria
Kester, J. C., & Fortune, S. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.869543 · Cited by 202 · cited 1×
“It refers to the whole population that can survive a transient exposure to antifungals at otherwise lethal concentrations, without an increase in the antifungal MIC [104].”
Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata
Healey, K., & Perlin, D. S. (2018) · doi:10.20944/preprints201808.0306.v1 · Cited by 194
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194
Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents
Jacobs, S. E., Jacobs, J. L., Dennis, E. K., Taimur, S., Rana, M., Patel, D., Gitman, M., Patel, G., Schaefer, S., Iyer, K., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00053-22 · Cited by 190 · cited 6×
“…spp., upregulation of the efflux transporter genes CDR1 , MDR1 and mutations in transcriptional factor TAC1B and in the genes ERG11 and ERG3 [82,84–87], which result in for example, primary sequence changes Y132F and R398I in C. parapsilosis lanosterol 14 α -demethylase [85], have been…”
InfluentialPublisher Correction: Definitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0207-4 · Cited by 185 · cited 1×
“%) time [103].”
Dambuza, I. M., Drake, T., Chapuis, A., Zhou, X., Correia, J., Taylor-Smith, L., LeGrave, N., Rasmussen, T., Fisher, M. C., Bicanic, T., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006978 · Cited by 182
Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179 · cited 6×
“For fungi, a mouse model showed that heteroresistant C. cryptococcus isolates suppress the host immune response to enhance evasion, achieve higher fungal burden in different organs, and increase virulence [48,102].”
InfluentialA Tetraploid Intermediate Precedes Aneuploid Formation in Yeasts Exposed to Fluconazole
Harrison, B. D., Hashemi, J., Bibi, M., Pulver, R., Bavli, D., Nahmias, Y., Wellington, M., Sapiro, G., & Berman, J. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001815 · Cited by 174 · cited 4×
“Harrison et al. reported the appearance of “trimeras”, connected cells composed of a mother, a daughter, and a granddaughter bud, after exposure to fluconazole [131].”
InfluentialSantangelo, R., Zoellner, H., Sorrell, T., Wilson, C., Donald, C., Djordjevic, J., Shounan, Y., & Wright, L. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2229-2239.2004 · Cited by 169 · cited 2×
“Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67],…”
Emerging and reemerging fungal infections
Lockhart, S. R., & Guarner, J. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.04.010 · Cited by 169 · cited 1×
“Fungal infections pose a significant and growing threat to public health worldwide, particularly in immunocompromised patients [1,2].”
Polyploid titan cells produce haploid and aneuploid progeny to promote stress adaptation
Gerstein, A. C., Fu, M. S., Mukaremera, L., Li, Z., Ormerod, K. L., Fraser, J. A., Berman, J., & Nielsen, K. (2015) · mBio · doi:10.1128/mbio.01340-15 · Cited by 167 · cited 2×
“Furthermore, a single titan mother cell produced multiple types of aneuploid daughter cells, which might contribute to the survivability of progeny under different environmental stresses [56].”
Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis
Stone, N. R. H., Rhodes, J., Fisher, M. C., Mfinanga, S., Kivuyo, S., Rugemalila, J., Segal, E. S., Needleman, L., Molloy, S. F., Kwon-Chung, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124516 · Cited by 167 · cited 3×
“A study of C. neoformans showed that 5-FC effectively suppress fluconazole-induced heteroresistance, suggesting the importance of combined therapy [142].”
InfluentialMarr, K. A., Lyons, C. N., Rustad, T., Bowden, R. A., & White, T. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2584 · Cited by 166 · cited 2×
“Marr et al. demonstrated that the induction effect of fluconazole on heteroresistance involved elevation of mRNA levels for ABC superfamily CDR genes [145].”
Liu, J.-Y., & Dickter, J. K. (2020) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2020.06.001 · Cited by 166
Dermatophyte Infections Worldwide: Increase in Incidence and Associated Antifungal Resistance
Kruithoff, C., Gamal, A., McCormick, T. S., & Ghannoum, M. A. (2023) · Life · doi:10.3390/life14010001 · Cited by 163
Villena, S. N., Pinheiro, R. O., Pinheiro, C. S., Nunes, M. P., Takiya, C. M., DosReis, G. A., Previato, J. O., Mendonça-Previato, L., & Freire-de-Lima, C. G. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01125.x · Cited by 148
Echinocandins in antifungal pharmacotherapy
Patil, A., & Majumdar, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12780 · Cited by 145
Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs
Todd, R. T., & Selmecki, A. (2020) · eLife · doi:10.7554/elife.58349 · Cited by 138 · cited 2×
“In vitro evolution during fluconazole exposure is relatively slow, compared to C. albicans , and mainly composed of a single nucleotide polymorphism (SNP), with aneuploidy a minority effect [135,136].”
Chrisman, C. J., Albuquerque, P., Guimaraes, A. J., Nieves, E., & Casadevall, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002047 · Cited by 128
Sionov, E., Chang, Y. C., & Kwon-Chung, K. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00694-13 · Cited by 112 · cited 2×
“As for high-level heteroresistant strains in brain-infected mice, if untreated their 20-day mortality rate can reach 100% [160].”
Haploidy, diploidy and evolution of antifungal drug resistance in Saccharomyces cerevisiae
Anderson, J. B., Sirjusingh, C., & Ricker, N. (2004) · Genetics · doi:10.1534/genetics.104.033266 · Cited by 111 · cited 1×
“Due to its haploid genome, some SNP changes in C. auris may have immediate phenotypic effects [137].”
Aneuploidy Causes Non-genetic Individuality
Beach, R. R., Ricci-Tam, C., Brennan, C. M., Moomau, C. A., Hsu, P.-H., Hua, B., Silberman, R. E., Springer, M., & Amon, A. (2017) · Cell · doi:10.1016/j.cell.2017.03.021 · Cited by 109 · cited 1×
“Importantly, its reversibility offers a dynamic mechanism for fungi to balance adaptation and stability, in the population and for individuals [151,155].”
Piano, S. S., Bunchorntavakul, C., Marciano, S., & Reddy, K. R. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00078-5 · Cited by 108
Heteroresistance of Cryptococcus gattii to Fluconazole
Varma, A., & Kwon-Chung, K. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-10 · Cited by 103 · cited 1×
“A comparative study showed that C. gattii showed a higher level of heteroresistance to fluconazole than C. neoformans [159].”
Billmyre, R. B., Applen Clancey, S., Li, L. X., Doering, T. L., & Heitman, J. (2020) · Nature Communications · doi:10.1038/s41467-019-13890-z · Cited by 102 · cited 1×
“…of MFS7 , a multidrug transporter protein that mediated azole-5-FC cross-resistance in Clavispora lusitaniae (formerly Candida lusitaniae ) [94] Billmyre et al. found that deletion of the mismatch repair gene, MSH2 , in C. deuterogattii also led to an elevated rate of 5-FC resistance [95].”
The eagle effect and antibiotic-induced persistence: two sides of the same coin?
Prasetyoputri, A., Jarrad, A. M., Cooper, M. A., & Blaskovich, M. A. T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.10.007 · Cited by 101 · cited 1×
“Cell wall remodeling contributes to echinocandin tolerance, with changes in β -glucan synthesis or increased production of compensatory components, like chitin, strengthening the cell wall and reducing drug efficacy [118,119].”
Aneuploidy Enables Cross-Adaptation to Unrelated Drugs
Yang, F., Teoh, F., Tan, A. S. M., Cao, Y., Pavelka, N., & Berman, J. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz104 · Cited by 101 · cited 2×
“C. albicans ’ heteroresistance to echinocandins is related to chr2, as chr2 trisomy can be induced after exposure to caspofungin [132].”
Giles, S. S., Batinić-Haberle, I., Perfect, J. R., & Cox, G. M. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.1.46-54.2005 · Cited by 99 · cited 2×
“Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67],…”
Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi
Delma, F. Z., Al-Hatmi, A. M. S., Brüggemann, R. J. M., Melchers, W. J. G., de Hoog, S., Verweij, P. E., & Buil, J. B. (2021) · Journal of Fungi · doi:10.3390/jof7110909 · Cited by 96 · cited 1×
“…i.e., mutations in any one or more of the key enzyme genes of the pyrimidine salvage pathway, which may involve mutations in the genes encoding the cytosine permease FCY2 , purine FCY1 encoding the cytosine deaminase, FUR1 encoding the uracil phosphoribosyl transferase, and ADE17 [82,93].”
Liu, Q., Via, L. E., Luo, T., Liang, L., Liu, X., Wu, S., Shen, Q., Wei, W., Ruan, X., Yuan, X., et al. (2015) · Scientific Reports · doi:10.1038/srep17507 · Cited by 95
Sun, T.-S., Ju, X., Gao, H.-L., Wang, T., Thiele, D. J., Li, J.-Y., Wang, Z.-Y., & Ding, C. (2014) · Nature Communications · doi:10.1038/ncomms6550 · Cited by 94
Self-citationInvasive fungal infections in neonates: a review
Weimer, K. E. D., Smith, P. B., Puia‐Dumitrescu, M., & Aleem, S. (2021) · Pediatric Research · doi:10.1038/s41390-021-01842-7 · Cited by 91
Ben-Ami, R., Zimmerman, O., Finn, T., Amit, S., Novikov, A., Wertheimer, N., Lurie-Weinberger, M., & Berman, J. (2016) · mBio · doi:10.1128/mbio.00655-16 · Cited by 88 · cited 6×
“A study of heteroresistance properties showed that the incremental effects of multiple binary genetic switches, including on the efflux pumps CDR1 , PDH1 , PDR1 and SNQ1 , etc. produced a spectrum of heteroresistance rather than binary states, in N. glabrata [99].”
InfluentialThe role of Candida albicans stress response pathways in antifungal tolerance and resistance
Iyer, K. R., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.103953 · Cited by 88 · cited 1×
“In addition, activation of cellular stress response pathways, such as the heat shock protein (Hsp) and calcineurin pathways, has been shown to contribute to echinocandin tolerance in C. albicans [120,121].”
Jackson, A. T., Nussbaum, J. C., Phulusa, J., Namarika, D., Chikasema, M., Kanyemba, C., Jarvis, J. N., Jaffar, S., Hosseinipour, M. C., van der Horst, C., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328354b419 · Cited by 86
Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82 · cited 4×
“…spp., upregulation of the efflux transporter genes CDR1 , MDR1 and mutations in transcriptional factor TAC1B and in the genes ERG11 and ERG3 [82,84–87], which result in for example, primary sequence changes Y132F and R398I in C. parapsilosis lanosterol 14 α -demethylase [85], have been…”
InfluentialBurrack, L. S., Todd, R. T., Soisangwan, N., Wiederhold, N. P., & Selmecki, A. (2022) · mBio · doi:10.1128/mbio.00842-22 · Cited by 82 · cited 1×
“In vitro evolution during fluconazole exposure is relatively slow, compared to C. albicans , and mainly composed of a single nucleotide polymorphism (SNP), with aneuploidy a minority effect [135,136].”
Yang, F., Zhang, L., Wakabayashi, H., Myers, J., Jiang, Y., Cao, Y., Jimenez-Ortigosa, C., Perlin, D. S., & Rustchenko, E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00071-17 · Cited by 81 · cited 3×
“However, the genes involved and whether they act together in echinocandin heteroresistance is not clear [118].”
Hope, W., Stone, N. R. H., Johnson, A., McEntee, L., Farrington, N., Santoro-Castelazo, A., Liu, X., Lucaci, A., Hughes, M., Oliver, J. D., et al. (2019) · mBio · doi:10.1128/mbio.02575-19 · Cited by 70 · cited 4×
“This limitation arises because heteroresistant subpopulations may exist at low frequencies or exhibit resistance only under specific conditions, such as prolonged exposure to antifungal agents or within certain host environments [153,165,167,168].”
InfluentialThe Dynamic Fungal Genome: Polyploidy, Aneuploidy and Copy Number Variation in Response to Stress
Vande Zande, P., Zhou, X., & Selmecki, A. (2023) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041320-112443 · Cited by 70 · cited 2×
“By altering gene dosage or expression levels, aneuploidy allows fungi to quickly adjust to adverse conditions without permanent genetic mutations, promoting survival in fluctuating environments [99,129,145,152,154].”
Cytochrome peroxidase contributes to the antioxidant defense of
Giles, S. S., Perfect, J. R., & Cox, G. M. (2004) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2004.09.003 · Cited by 64
Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae
Kannan, A., Asner, S. A., Trachsel, E., Kelly, S., Parker, J., & Sanglard, D. (2019) · mBio · doi:10.1128/mbio.02512-19 · Cited by 63 · cited 1×
“…of MFS7 , a multidrug transporter protein that mediated azole-5-FC cross-resistance in Clavispora lusitaniae (formerly Candida lusitaniae ) [94] Billmyre et al. found that deletion of the mismatch repair gene, MSH2 , in C. deuterogattii also led to an elevated rate of 5-FC resistance [95].”
Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63 · cited 2×
“However, for fungistatic drugs (e.g., azoles), tolerance has a different definition, i.e., the ability of a tolerant strain to overcome growth inhibition faster than a sensitive strain at drug concentrations above the MIC [106].”
Yamazumi, T., Pfaller, M. A., Messer, S. A., Houston, A. K., Boyken, L., Hollis, R. J., Furuta, I., & Jones, R. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.267-272.2003 · Cited by 62 · cited 2×
“For C. neoformans and C. gattii , the heteroresistance to fluconazole is intrinsic and increased resistance can be induced [19,102].”
Tian, Y., Zhang, Q., Wen, L., & Chen, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00152-21 · Cited by 62 · cited 3×
“For example, combination polymyxin B and tigecycline therapy was shown to kill both the polymyxin B-and tigecycline-heteroresistant Klebsiella pneumoniae [174].”
Yang, F., Scopel, E. F. C., Li, H., Sun, L.-L., Kawar, N., Cao, Y.-B., Jiang, Y.-Y., & Berman, J. (2023) · mBio · doi:10.1128/mbio.00227-23 · Cited by 62 · cited 1×
“This tolerance is typically temperature-independent and frequently associated with aneuploidy, which may be lost upon temperature changes or ploidy recovery [114,115].”
Zhai, B., Liao, C., Jaggavarapu, S., Tang, Y., Rolling, T., Ning, Y., Sun, T., Bergin, S. A., Gjonbalaj, M., Miranda, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03183-4 · Cited by 62 · cited 4×
“In C. parapsilosis , multi-center studies have shown that heteroresistance facilitates breakthrough infections in immunocompromised patients and may cause prophylaxis failure [3].”
InfluentialSelf-citationA Double-Edged Sword: Aneuploidy is a Prevalent Strategy in Fungal Adaptation
Tsai, H.-J., & Nelliat, A. (2019) · Genes · doi:10.3390/genes10100787 · Cited by 60 · cited 3×
“Importantly, its reversibility offers a dynamic mechanism for fungi to balance adaptation and stability, in the population and for individuals [151,155].”
Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans
Yang, F., Gritsenko, V., Slor Futterman, Y., Gao, L., Zhen, C., Lu, H., Jiang, Y.-Y., & Berman, J. (2021) · mBio · doi:10.1128/mbio.02272-21 · Cited by 59 · cited 1×
“This tolerance is typically temperature-independent and frequently associated with aneuploidy, which may be lost upon temperature changes or ploidy recovery [114,115].”
Arastehfar, A., Daneshnia, F., Cabrera, N., Penalva-Lopez, S., Sarathy, J., Zimmerman, M., Shor, E., & Perlin, D. S. (2023) · Nature Communications · doi:10.1038/s41467-023-36882-6 · Cited by 58 · cited 5×
“Despite initial susceptibility to the drug, heteroresistant subpopulations can expand during therapy, partially due to antifungal exposure, characterized as the emergence of resistance-related genetic mutations, and clinically as relapse or progression of the infection [110,151–153].”
InfluentialCandida auris -associated hospitalizations and outbreaks, China, 2018–2023
Bing, J., Du, H., Guo, P., Hu, T., Xiao, M., Lu, S., Nobile, C. J., Chu, H., & Huang, G. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2302843 · Cited by 58
Ngamskulrungroj, P., Chang, Y., Hansen, B., Bugge, C., Fischer, E., & Kwon-Chung, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033022 · Cited by 56 · cited 2×
“Ngamskulrungroj et al. demonstrated a high incidence of chr4 disomy, which may be related to SEY1 (GTPase with a role in Endoplasmic Reticulum morphology), GCS2 (ADP-ribosylation factor GTPase activating proteins) or GLO3 (ADP-ribosylation factor GTPase activating proteins) genes [143].”
Fan, X., Dai, R.-C., Zhang, S., Geng, Y.-Y., Kang, M., Guo, D.-W., Mei, Y.-N., Pan, Y.-H., Sun, Z.-Y., Xu, Y.-C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43380-2 · Cited by 55
Self-citationCopper-only superoxide dismutase enzymes and iron starvation stress in Candida fungal pathogens
Schatzman, S. S., Peterson, R. L., Teka, M., He, B., Cabelli, D. E., Cormack, B. P., & Culotta, V. C. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011084 · Cited by 54 · cited 1×
“Resistance to AmB in both species involves a variety of mechanisms, including alterations in cell membrane composition, cellular metabolic state, iron homeostasis, and ROS metabolism [58,77,78,96].”
Evans, R. J., Li, Z., Hughes, W. S., Djordjevic, J. T., Nielsen, K., & May, R. C. (2015) · Infection and Immunity · doi:10.1128/iai.03104-14 · Cited by 53
MODE OF ACTION OF STREPTOMYCIN ON TYPE b HEMOPHILUS INFLUENZAE
Alexander, H. E., & Leidy, G. (1947) · Journal of Experimental Medicine · doi:10.1084/jem.85.6.607 · Cited by 51 · cited 2×
“Heteroresistance, a concept fi rst introduced for bacteria, is a form in which a minority subpopulation of resistant phenotype cells has a higher MIC, sometimes involving as few as one in one million cells, that coexists with a majority population of susceptible cells with a lower MIC [15].”
Kargarpour Kamakoli, M., Sadegh, H. R., Farmanfarmaei, G., Masoumi, M., Fateh, A., Javadi, G., Rahimi Jamnani, F., Vaziri, F., & Siadat, S. D. (2017) · Scientific Reports · doi:10.1038/srep41410 · Cited by 51
Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection
Levinson, T., Dahan, A., Novikov, A., Paran, Y., Berman, J., & Ben‐Ami, R. (2021) · Mycoses · doi:10.1111/myc.13191 · Cited by 50
Yang, F., Gritsenko, V., Lu, H., Zhen, C., Gao, L., Berman, J., & Jiang, Y.-Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00723-21 · Cited by 49 · cited 4×
“However, unlike C. neoformans , exposure of C. parapsilosis to tunicamycin did not reveal any relationship between aneuploidy and heteroresistance [3,153].”
InfluentialInvasive Fungal Pneumonia in Immunocompromised Patients
Godoy, M. C. B., Pria, H. R. F. D., Truong, M. T., Shroff, G. S., & Marom, E. M. (2022) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2022.01.006 · Cited by 49
Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System
Hamed, M. F., Araújo, G. R. D. S., Munzen, M. E., Reguera-Gómez, M., Epstein, C., Lee, H. H., Frasés, S., & Martinez, L. R. (2023) · mBio · doi:10.1128/mbio.02640-22 · Cited by 49
Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates
Zheng, C., Li, S., Luo, Z., Pi, R., Sun, H., He, Q., Tang, K., Luo, M., Li, Y., Couvin, D., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03507-14 · Cited by 48
Self-citationEscribano, P., Recio, S., Peláez, T., González-Rivera, M., Bouza, E., & Guinea, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00301-11 · Cited by 48 · cited 1×
“Progressive itraconazole exposure in vitro can reproduce such phenomena, independent of the mutation in cyp51A gene [162].”
Unmasking the Amphotericin B Resistance Mechanisms in Candida haemulonii Species Complex
Silva, L. N., Oliveira, S. S. C., Magalhães, L. B., Andrade Neto, V. V., Torres-Santos, E. C., Carvalho, M. D. C., Pereira, M. D., Branquinha, M. H., & Santos, A. L. S. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00117 · Cited by 48 · cited 2×
“Fungal resistance to AmB is less common but has been reported in species such as Candidazymus auris (formerly Candida auris ) and the Candidazymus haemulonii (formerly Candida haemulonii ) complex [82,96].”
Spallone, A., & Schwartz, I. S. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.014 · Cited by 48 · cited 1×
“Fungal infections pose a significant and growing threat to public health worldwide, particularly in immunocompromised patients [1,2].”
Huang, S., Wu, A. Y.-J., Lee, S. S., Huang, Y., Lee, C.-Y., Yang, T.-L., Wang, H.-W., Chen, H.-J., Chen, Y. C., Ho, T., et al. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.12.004 · Cited by 48
Altamirano, S., Fang, D., Simmons, C., Sridhar, S., Wu, P., Sanyal, K., & Kozubowski, L. (2017) · mSphere · doi:10.1128/msphere.00205-17 · Cited by 46 · cited 1×
“This resulted in populations with increased DNA, whose content grow better in the presence of fluconazole, increasing aneuploidy and survival [161].”
Brain glucose induces tolerance of Cryptococcus neoformans to amphotericin B during meningitis
Chen, L., Tian, X., Zhang, L., Wang, W., Hu, P., Ma, Z., Li, Y., Li, S., Shen, Z., Fan, X., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01561-1 · Cited by 46 · cited 1×
“This process is mediated by the zinc-finger transcription factor Mig1 and involves more complex mechanisms, such as the inhibition of ergosterol synthesis and the promotion of competing compounds that contribute to antifungal tolerance [116].”
Self-citationFungicide-tolerant persister formation during cryptococcal pulmonary infection
Ke, W., Xie, Y., Chen, Y., Ding, H., Ye, L., Qiu, H., Li, H., Zhang, L., Chen, L., Tian, X., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2023.12.012 · Cited by 45 · cited 3×
“Ke et al. constructed a mouse model of pulmonary infection and demonstrated that AmB-tolerant persisters are enriched in C. neoformans cells with high levels of the stationary-phase protein Sps1 and the metabolic marker ergothioneine [112].”
Ferreira, G. F., Santos, J. R. A., Costa, M. C. D., Holanda, R. A. D., Denadai, Â. M. L., Freitas, G. J. C. D., Santos, Á. R. C., Tavares, P. B., Paixão, T. A., & Santos, D. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00466-15 · Cited by 44
Impact of bacterial persisters on their host
Moldoveanu, A. L., Rycroft, J. A., & Helaine, S. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.07.006 · Cited by 44 · cited 2×
“Importantly, persistence is characterized by a biphasic killing curve, whereas tolerance is not [109].”
Deletion of ADA2 Increases Antifungal Drug Susceptibility and Virulence in Candida glabrata
Yu, S.-J., Chang, Y.-L., & Chen, Y.-L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01924-17 · Cited by 43 · cited 3×
“Yu et al. found that the ADA2 gene of Nakaseomyces glabrata (formerly Candida glabrata ) is associated with resistance to three classes of antifungals, as evidenced by ∆ ada2 knockout strains having significantly reduced MIC values [51].”
Beyond resistance: antifungal heteroresistance and antifungal tolerance in fungal pathogens
Yang, F., & Berman, J. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102439 · Cited by 42 · cited 1×
“Aneuploidy is a common heritable mechanism responsible for the most widely studied form of antifungal heteroresistance [148–150].”
Cherkaoui, A., Diene, S. M., Renzoni, A., Emonet, S., Renzi, G., François, P., & Schrenzel, J. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.009 · Cited by 41
Comparative Transcriptomics Reveal Possible Mechanisms of Amphotericin B Resistance in Candida auris
Shivarathri, R., Jenull, S., Chauhan, M., Singh, A., Mazumdar, R., Chowdhary, A., Kuchler, K., & Chauhan, N. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02276-21 · Cited by 41 · cited 1×
“Resistance to AmB in both species involves a variety of mechanisms, including alterations in cell membrane composition, cellular metabolic state, iron homeostasis, and ROS metabolism [58,77,78,96].”
Winski, C. J., Qian, Y., Mobashery, S., & Santiago-Tirado, F. H. (2022) · mBio · doi:10.1128/mbio.01539-22 · Cited by 37 · cited 1×
“This limitation arises because heteroresistant subpopulations may exist at low frequencies or exhibit resistance only under specific conditions, such as prolonged exposure to antifungal agents or within certain host environments [153,165,167,168].”
Francis, V. I., Liddle, C., Camacho, E., Kulkarni, M., Santos, S. R. D., Harvey, J. A., Ballou, E. R., Thomson, D. D., Brown, G. D., Hardwick, J. M., et al. (2024) · mBio · doi:10.1128/mbio.03078-23 · Cited by 36
Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
Xu, Y., Zheng, X., Zeng, W., Chen, T., Liao, W., Qian, J., Lin, J., Zhou, C., Tian, X., Cao, J., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s249475 · Cited by 35
Self-citationKon, H., Hameir, A., Nutman, A., Temkin, E., Keren Paz, A., Lellouche, J., Schwartz, D., Weiss, D. S., Kaye, K. S., Daikos, G. L., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05093-22 · Cited by 35 · cited 1×
“In bacteria, heteroresistance may progress during antibiotic therapy, leading to changes in clinical tests and treatment failures and even creating an antimicrobial resistance reservoir [20,164].”
Chang, Y. C., Khanal Lamichhane, A., & Kwon-Chung, K. J. (2018) · mBio · doi:10.1128/mbio.01290-18 · Cited by 34 · cited 1×
“This limitation arises because heteroresistant subpopulations may exist at low frequencies or exhibit resistance only under specific conditions, such as prolonged exposure to antifungal agents or within certain host environments [153,165,167,168].”
Dermatophyte Infections Worldwide: Increase in Incidence and Associated Antifungal ResistancePreprint
Kruithoff, C., Gamal, A., McCormick, T. S., et al. (2023) · Preprints.org · doi:10.20944/preprints202311.1060.v1 · Cited by 33
Fattouh, N., Hdayed, D., Geukgeuzian, G., Tokajian, S. T., & Khalaf, R. A. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103575 · Cited by 32 · cited 1×
“…spp., upregulation of the efflux transporter genes CDR1 , MDR1 and mutations in transcriptional factor TAC1B and in the genes ERG11 and ERG3 [82,84–87], which result in for example, primary sequence changes Y132F and R398I in C. parapsilosis lanosterol 14 α -demethylase [85], have been associated…”
Dai, Y., Li, C., Yi, J., Qin, Q., Liu, B., & Qiao, L. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00494 · Cited by 31 · cited 1×
“These include techniques such as flow cytometry, single-cell RNA sequencing (scRNA-seq), and microfluidics-based assays, allowing for the analysis of gene expression, cell viability, and drug tolerance in individual fungal cells [170,171].”
Bosco-Borgeat, M. E., Mazza, M., Taverna, C. G., Córdoba, S., Murisengo, O. A., Vivot, W., & Davel, G. (2016) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2016.03.003 · Cited by 30
Gleason, M. K., & Fraenkel-Conrat, H. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.5.1528 · Cited by 29
Oxidative imbalance in Candida tropicalis biofilms and its relation with persister cells
da Silva, M. A., Baronetti, J. L., Páez, P. L., & Paraje, M. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.598834 · Cited by 28 · cited 1×
“The formation of persister cells does not require biofilm formation, but biofilm-containing persister populations are more tolerant of oxidative stress and better resist the fungicidal effects of AmB [125].”
Wang, Y., Ma, X., Zhao, L., He, Y., Yu, W., Fu, S., Ni, W., & Gao, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.868991 · Cited by 27
Mezcord, V., Escalante, J., Nishimura, B., Traglia, G. M., Sharma, R., Valle, Q., Tuttobene, M. R., Subils, T., Marin, I., Pasterán, F., et al. (2023) · doi:10.20944/preprints202306.0950.v1 · Cited by 27
Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis
Chen, Y., Ji, L., Liu, Q., Li, J., Hong, C., Jiang, Q., Gan, M., Takiff, H. E., Yu, W., Tan, W., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab011 · Cited by 26 · cited 1×
“In bacteria, heteroresistance may progress during antibiotic therapy, leading to changes in clinical tests and treatment failures and even creating an antimicrobial resistance reservoir [20,164].”
Sah, S. K., Hayes, J. J., & Rustchenko, E. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009564 · Cited by 26 · cited 3×
“Loss of chr5 can result in enhanced susceptibility to azoles [130], and can also lead to enhanced susceptibility to AmB and increased resistance to 5-FC.”
Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata
Gohar, A. A., Badali, H., Shokohi, T., Nabili, M., Amirrajab, N., & Moazeni, M. (2017) · Mycopathologia · doi:10.1007/s11046-016-0074-8 · Cited by 25 · cited 2×
“By altering gene dosage or expression levels, aneuploidy allows fungi to quickly adjust to adverse conditions without permanent genetic mutations, promoting survival in fluctuating environments [99,129,145,152,154].”
Fukuzawa, S., Sato, T., Aoki, K., Yamamoto, S., Ogasawara, N., Nakajima, C., Suzuki, Y., Horiuchi, M., Takahashi, S., & Yokota, S. (2023) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-023-00610-1 · Cited by 25
Dumeaux, V., Massahi, S., Bettauer, V., Mottola, A., Dukovny, A., Khurdia, S. S., Costa, A. C. B. P., Omran, R. P., Simpson, S., Xie, J. L., et al. (2023) · eLife · doi:10.7554/elife.81406 · Cited by 25
Copy number variants of ERG11: Mechanism of azole resistance in Candida parapsilosis
Ning, Y., Dai, R., Zhang, L., Xu, Y., & Xiao, M. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00294-x · Cited by 25 · cited 1×
“Aneuploidy is a common heritable mechanism responsible for the most widely studied form of antifungal heteroresistance [148–150].”
Self-citation(2024) · doi:10.1101/2024.08.06.606879 · Cited by 25 · cited 2×
“Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67],…”
Peterson, P. P., Choi, J.-T., Fu, C., Cowen, L. E., Sun, S., Bahn, Y.-S., & Heitman, J. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012735 · Cited by 25
Novel ABC Transporter Associated with Fluconazole Resistance in Aging of Cryptococcus neoformans
Oliveira, N. K., Bhattacharya, S., Gambhir, R., Joshi, M., & Fries, B. C. (2022) · Journal of Fungi · doi:10.3390/jof8070677 · Cited by 25
Horianopoulos, L. C., Lee, C. W. J., Hu, G., Caza, M., & Kronstad, J. W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.727039 · Cited by 24
Novel ABC Transporter Associated with Fluconazole Resistance in Aging of Cryptococcus neoformans
Oliveira, N. K., Bhattacharya, S., Gambhir, R., Joshi, M., & Fries, B. C. (2022) · doi:10.20944/preprints202201.0263.v1 · Cited by 24
Mezcord, V., Escalante, J., Nishimura, B., Traglia, G. M., Sharma, R., Vallé, Q., Tuttobene, M. R., Subils, T., Marin, I., Pasterán, F. G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411752 · Cited by 24
Approaches for identifying and measuring heteroresistance in azole-susceptible Candida isolates
Gautier, C., Maciel, E. I., & Ene, I. V. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04041-23 · Cited by 23 · cited 3×
“For diagnosed fungal infections, it may lead to persistent infections that require longer or more aggressive treatment regimens [27–30].”
Xiong, Y., Han, Y., Zhao, Z., Gao, W., Ma, Y., Jiang, S., Wang, M., Zhang, Q., Zhou, Y., & Chen, Y. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s340652 · Cited by 22
Moreira, I. D. M. B., Cortez, A. C. A., de Souza, É. S., Pinheiro, S. B., de Souza Oliveira, J. G., Sadahiro, A., Cruz, K. S., Matsuura, A. B. J., Melhem, M. D. S. C., Frickmann, H., et al. (2022) · Medical Mycology · doi:10.1093/mmy/myac005 · Cited by 22 · cited 2×
“Several studies have confirmed the increased emergence of heteroresistance in clinical, compared with environmental, isolates, supporting the induction effect of antifungal exposure [101,158].”
Jo, J., Kwon, K. T., & Ko, K. S. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00914-6 · Cited by 22 · cited 1×
“Similarly in Acinetobacter baumannii , combined tigecycline and colistin therapy was bactericidal on TGC and colistin multi-heteroresistance [175].”
El Meouche, I., Jain, P., Jolly, M. K., & Capp, J.-P. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102069 · Cited by 22 · cited 1×
“As antifungals can increase levels of ROS, persister cells might obtain stronger antioxidant capacity by upregulating enzymes, like superoxide dismutases (SODs) or alkyl hydroperoxide reductase 1, etc. [127].”
Xue, P., Sánchez‐León, E., Hu, G., Lee, C. W. J., Black, B., Brisland, A., Li, H., Jung, W. H., & Kronstad, J. W. (2024) · mSphere · doi:10.1128/msphere.00250-24 · Cited by 21
Combination therapy with fluconazole and flucytosine for pulmonary cryptococcosis
Yamamoto, Y., Maesaki, S., Kakeya, H., Yanagihara, K., Ohno, H., Ogawa, K., Hirakata, Y., Tomono, K., Koga, H., Tashiro, T., et al. (2009) · Chemotherapy · doi:10.1159/000239603 · Cited by 20 · cited 1×
“Expanding the scope to all failed antifungal treatments, such as adding 5-FC or amphotericin B to fluconazole monotherapy, alleviates mortality rate and achieves up to 90% efficacy [177–179].”
Ploidy Variation and Spontaneous Haploid-Diploid Switching of Candida glabrata Clinical Isolates
Zheng, Q., Liu, J., Qin, J., Wang, B., Bing, J., Du, H., Li, M., Yu, F., & Huang, G. (2022) · mSphere · doi:10.1128/msphere.00260-22 · Cited by 20 · cited 1×
“N. glabrata N. glabrata was considered a haploid and an asexual organism for decades, but recent studies have reported the instability of clinical isolate genomes, mainly due to the frequent change in ploidy [157].”
Identification and Elimination of Antifungal Tolerance in Candida auris
Rasouli Koohi, S., Shankarnarayan, S. A., Galon, C. M., & Charlebois, D. A. (2023) · Biomedicines · doi:10.3390/biomedicines11030898 · Cited by 20 · cited 2×
“The reversibility of this property has been con fi rmed for several fungi species [107,108].”
Chadwick, B. J., Ristow, L. C., Xie, X., Krysan, D. J., & Lin, X. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01792-w · Cited by 20
Altamirano, S., Simmons, C., & Kozubowski, L. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00203 · Cited by 19 · cited 3×
“For C. neoformans , heteroresistance can be reduced or inhibited by several environmental factors, including temperature, media type, growth phase, and the age of cells [147].”
InfluentialThe Buoyancy of Cryptococcus neoformans Is Affected by Capsule Size
Vij, R., Cordero, R. J. B., & Casadevall, A. (2018) · mSphere · doi:10.1128/msphere.00534-18 · Cited by 19
Zhu, Y., Li, J., Lin, X., Huang, X., & Hoffmann, M. R. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01615 · Cited by 18 · cited 1×
“These include techniques such as flow cytometry, single-cell RNA sequencing (scRNA-seq), and microfluidics-based assays, allowing for the analysis of gene expression, cell viability, and drug tolerance in individual fungal cells [170,171].”
Cao, C., Wang, K., Wang, Y., Liu, T.-B., Rivera, A., & Xue, C. (2022) · Nature Communications · doi:10.1038/s41467-022-34151-6 · Cited by 18 · cited 1×
“One of its mechanisms is associated with the multiple types of aneuploid daughter cells produced by titan cells [56,140,141].”
Zhang, F., Ding, M., Yan, X., Bai, J., Li, Q., Zhang, B., Liang, Q., Liang, S., Wang, G., & Zhou, Y. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105162 · Cited by 17 · cited 2×
“An in vivo experiment with K. pneumoniae strain SWMUF35 -infected mice showed contra-dictory results compared to in vitro experiments, which classified the strain as amikacin susceptible [28].”
Li, W.-R., Zhang, Z.-Q., Liao, K., Wang, B.-B., Liu, H.-Z., Shi, Q.-S., Huang, X.-B., & Xie, X.-B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1105921 · Cited by 17
Rajakani, S. G., Xavier, B. B., Sey, A., Mariem, E. B., Lammens, C., Goossens, H., Glupczynski, Y., & Malhotra-Kumar, S. (2023) · Genes · doi:10.3390/genes14071426 · Cited by 17 · cited 1×
“For bacteria, a combination of several antibiotics serves as the preferred strategy [28,174–176].”
Mbangiwa, T., Sturny-Leclère, A., Lechiile, K., Kajanga, C., Boyer‐Chammard, T., Hoving, J. C., Leeme, T., Moyo, M., Youssouf, N. F., Lawrence, D. S., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00362-2 · Cited by 17
Dasilva, M. A., Andrada, K. F. C., Torales, M. M., Hughes, I. M., Pez, P., García-Martínez, J. C., & Paraje, M. G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02415-6 · Cited by 16 · cited 1×
“Inhibiting biofilms helps eradicate C. tropicalis persister cells [126].”
Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents
Odds, F. C., Cheesman, S. L., & Abbott, A. B. (1985) · Medical Mycology · doi:10.1080/00362178585380611 · Cited by 15
Ksiezopolska, E., Schikora-Tamarit, M. À., Carlos Nunez-Rodriguez, J., & Gabaldón, T. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1416509 · Cited by 15 · cited 2×
“Heteroresistance due to environmental stress may remain even after the stress [134].”
Liu, J., Liu, J., Su, X., Yang, L., Wang, Y., Wang, A., Xu, X., Li, M., Jiang, Y., & Peng, F. (2022) · BMC Neurology · doi:10.1186/s12883-022-02803-1 · Cited by 14 · cited 1×
“Expanding the scope to all failed antifungal treatments, such as adding 5-FC or amphotericin B to fluconazole monotherapy, alleviates mortality rate and achieves up to 90% efficacy [177–179].”
Kotilea, K., Iliadis, E., Nguyen, J., Salame, A., Mahler, T., Miendje Deyi, V. Y., & Bontems, P. (2023) · Helicobacter · doi:10.1111/hel.13006 · Cited by 14 · cited 1×
“For diagnosed fungal infections, it may lead to persistent infections that require longer or more aggressive treatment regimens [27–30].”
García-Barbazán, I., Torres-Cano, A., García-Rodas, R., Sachse, M., Luque, D., Megías, D., & Zaragoza, O. (2024) · mBio · doi:10.1128/mbio.02549-23 · Cited by 14 · cited 2×
“This process was associated with intracellular ROS accumulation and mitochondrial responses [141].”
Aneuploidy Underlies Brefeldin A‐Induced Antifungal Drug Resistance in Cryptococcus Neoformans
Zhang, Z.-H., Sun, L.-L., Fu, B.-Q., Deng, J., Jia, C.-L., Miao, M.-X., Yang, F., Cao, Y.-B., & Yan, T.-H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1397724 · Cited by 14 · cited 2×
“Zhang et al. found that the endoplasmic reticulum stress chemo inducer Brefeldin A led to aneuploidy in C. neoformans : disomy in chromosome 1 led to cross-resistance to two classes of antifungal drugs, fluconazole and 5-FC, plus hypersensitivity to AmB [139].”
Krzych, Ł. J., Putowski, Z., Gruca, K., & Pluta, M. P. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16221 · Cited by 13
In vivo development of fluconazole resistance in serial Cryptococcus gattii isolates from a cat
Sykes, J. E., Hodge, G., Singapuri, A., Yang, M. L., Gelli, A., & Thompson, G. R. (2016) · Medical Mycology · doi:10.1093/mmy/myw104 · Cited by 13
Mutants with heteroresistance to amphotericin B and fluconazole in Candida
Claudino, A. L. R., Peixoto Junior, R. F., Melhem, M. S. C., Szeszs, M. W., Lyon, J. P., Chavasco, J. K., & Franco, M. C. (2009) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822009000400028 · Cited by 12
Nitrogen concentration affects amphotericin B and fluconazole tolerance of pathogenic cryptococci
Bosch, C., Toplis, B., Vreulink, J.-M., Volschenk, H., & Botha, A. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa010 · Cited by 12 · cited 4×
“In C. neoformans , time kill assays have been used to study azole and AmB heteroresistance, revealing that subpopulations of cells can survive for prolonged periods despite the presence of high drug concentrations [57].”
InfluentialLee, Y.-M., Liu, Y.-M., & Chen, T. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09264-6 · Cited by 12
Zou, P., Liu, J., Li, P., & Luan, Q. (2024) · Antibiotics · doi:10.3390/antibiotics13060521 · Cited by 12 · cited 1×
“Such mechanisms have been confirmed via SOD inhibition which reduces persistence levels [128].”
Huang, Y., Zhang, Y., Yang, S., Lu, H., Yu, H., Wang, X., Jia, X., Tang, D., Wu, L., Huang, S., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00725-24 · Cited by 12 · cited 2×
“Clinically, it refers to persistent infection, treatment failure, or relapse, despite in vitro susceptibility results indicating sensitivity [97,98].”
Nurjadi, D., Chanthalangsy, Q., Zizmann, E., Stuermer, V., Moll, M., Klein, S., Boutin, S., Heeg, K., & Zanger, P. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01510-21 · Cited by 10 · cited 1×
“One study demonstrated that Trimethoprim-Sulfamethoxazole heteroresistant Staphylococcus aureus strains gave near identical mortality as the resistant strains, indicating clinical consequences [163].”
Husain, F., Yadav, A., Sah, S. K., Hayes, J. J., & Rustchenko, E. (2022) · Microorganisms · doi:10.3390/microorganisms11010023 · Cited by 10 · cited 2×
“It is also related to chr5, as chr5 aneuploidy after caspofungin exposure gave cross-resistance to caspofungin, micafungin and anidulafungin [133].”
Unraveling the mechanism of thermotolerance by Set302 in Cryptococcus neoformans
Ni, Y., Qiao, Y., Tian, X., Li, H., Meng, Y., Li, C., Du, W., Sun, T., Zhu, K., Huang, W., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04202-23 · Cited by 10 · cited 1×
“…adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, 68, 68, 69] 69 , ], etc. etc.”
Self-citationProteomic Analysis of Copper Toxicity in Human Fungal Pathogen Cryptococcus neoformans
Sun, T., Li, Y., Li, Y., Li, H., Gong, Y., Wu, J., Ning, Y., Ding, C., & Xu, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.662404 · Cited by 9
Self-citationLee, C. W. J., Brisland, A., Qu, X., Horianopoulos, L. C., Hu, G., Mayer, F. L., & Kronstad, J. W. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1448229 · Cited by 9
Protocols for Measuring Tolerant and Heteroresistant Drug Responses of Pathogenic Yeasts
Lyons, N., & Berman, J. (2023) · Methods in Molecular Biology · doi:10.1007/978-1-0716-3155-3_6 · Cited by 8 · cited 4×
“This phenomenon can be measured using broth microdilution or disk diffusion assays [98].”
InfluentialLiu, B., Zeng, G., Dong, J., Liu, X., Shuru, C., & Liu, J. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08926-1 · Cited by 8
Yoo, K., Bhattacharya, S., Oliveira, N. K., Pereira de Sa, N., Matos, G. S., Del Poeta, M., & Fries, B. C. (2024) · mBio · doi:10.1128/mbio.01847-24 · Cited by 8 · cited 1×
“In C. neoformans , altered mitochondrial metabolism caused by cell ageing drives increased ergosterol synthesis and ABC transporter upregulation and leads to azole tolerance [117].”
Insight into Virulence and Mechanisms of Amphotericin B Resistance in the Candida haemulonii Complex
Huang, Y., Su, Y., Chen, X., Xiao, M., & Xu, Y. (2024) · Journal of Fungi · doi:10.3390/jof10090615 · Cited by 8 · cited 4×
“The molecular mechanisms of resistance to AmB in C. haemulonii were systematically discussed in the author’s previous review [40].”
InfluentialSelf-citationŠtefánek, M., Garaiová, M., Valček, A., Jordao, L., & Bujdáková, H. (2023) · Cells · doi:10.3390/cells12121579 · Cited by 7 · cited 1×
“…transporter genes CDR1 , MDR1 and mutations in transcriptional factor TAC1B and in the genes ERG11 and ERG3 [82,84–87], which result in for example, primary sequence changes Y132F and R398I in C. parapsilosis lanosterol 14 α -demethylase [85], have been associated with fluconazole resistance.”
Adams-Sapper, S., Gayoso, A., & Riley, L. W. (2018) · Journal of Pathogens · doi:10.1155/2018/3028290 · Cited by 7
Kessel, J. M., Rossaert, A.-C., Lingscheid, T., Grothe, J. H., Harrer, T., Wyen, C., Tominski, D., Bollinger, T., Kehr, A. K., Kalbitz, S., et al. (2024) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2024.151614 · Cited by 5 · cited 2×
“Fungi are signi fi cant eukaryotic pathogens in humans capable of causing infections ranging from super fi cial to life-threatening systemic diseases [8,31–40].”
Qin, Y., Zou, X., Jin, Y., et al. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s476270 · Cited by 5
Banerjee, T., Adwityama, A., Sharma, S., Mishra, K., Prusti, P., & Maitra, U. (2024) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2023.100494 · Cited by 4 · cited 1×
“Conventional antifungal susceptibility testing methods, such as broth microdilution and disk diffusion assays, may not detect heteroresistant subpopulations [165,166].”
Isolated cryptococcal osteomyelitis in the setting of immune reconstitution inflammatory syndrome
Horton, P., Long, A., Alfattal, R., Qiu, S., & Hornak, J. P. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241230149 · Cited by 4
Bosch, C., Volschenk, H., & Botha, A. (2021) · FEMS Microbiology Letters · doi:10.1093/femsle/fnab134 · Cited by 3
Arthritis caused by Cryptococcus neoformans infection: A case report
Min, J., Zhao, Y. H., Du, J., et al. (2023) · Biomedical Reports · doi:10.3892/br.2023.1694 · Cited by 3
Organizing pneumonia secondary to pulmonary cryptococcosis in immunocompromised patient
Saito, Z., Ito, T., Imakita, T., et al. (2023) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2023.101975 · Cited by 3
Folorunso, O. S., & Sebolai, O. M. (2024) · International Journal of Microbiology · doi:10.1155/2024/5566438 · Cited by 3
Omura, M., Komori, A., Tamura, T., Han, H. S., Kano, R., & Makimura, K. (2024) · Medical Mycology · doi:10.1093/mmy/myae085 · Cited by 3
Şababoğlu, E., İPEK, V., GÖKÇE, H. İ., Ayozger, L. E. O., & Olguner, B. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101501 · Cited by 2
Haematologic and Urologic Manifestations of Cryptococcus neoformans
Morgan, J., Vardanega, J., Yue, M., & Gassiep, I. (2024) · Case Reports in Infectious Diseases · doi:10.1155/2024/2245391 · Cited by 1
Measuring Urease and Phospholipase Secretion in Cryptococcus neoformans
Hoffman, H. J., & McClelland, E. E. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3722-7_18 · Cited by 1 · cited 1×
“…adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, Their pathogenicity stems from immune evasion [41–51], adaptation to changing pH conditions and nutrient availability [45,47,52–67], tissue invasions [40,42–44, 68, 68, 69] 69 , ], etc. etc.”
Cited by
Understanding the mechanisms of resistance to azole antifungals in Candida species
Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 77
Self-citationPublic Health Risks of Pathogenic Fungi in China
Miao, B., Yao, J., Zhang, S., Guo, X., Geng, Y., & Gong, J. (2026) · iFungi · doi:10.26599/ifungi.2026.9670003 · Cited by 19
Antifungal persistence: Clinical relevance and mechanisms
Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H. (2025) · PLoS pathogens · doi:10.1371/journal.ppat.1013456 · Cited by 12
Ferrara, G. A., Spruijtenburg, B., Meijer, E. F. J., Meis, J. F. G. M., Ceballos-Garzón, A., & Cáceres, D. H. (2025) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2025.100745 · Cited by 8
Harrington, A. A., Nickels, T. J., & Cunningham, K. W. (2026) · mBio · doi:10.1128/mbio.02546-25 · Cited by 4
Metadata
- Authors
- Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Sun, Tianshu
- Li, Yingxing
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2025-02-13
- Volume
- 11
- Issue
- 2
- Pages
- 143
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC11856953
- OpenAlex
- W4407526169
- Cited by
- 18
- References
- 180
- Citations by year
- 2026: 12 · 2025: 6
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National High Level Hospital Clinical Research Funding (2022-PUMCH-C-052)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- antifungal resistance, fungal pathogens, drug tolerance, fungal persistence, susceptibility testing, treatment failure, recurrent fungal infection, immunocompromised patients, antifungal therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.